Relationship between peripheral blood inflammation indicators and short-term adverse outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis

This study aimed to assess the correlation between neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and systemic immunoinflammatory index (SII) levels, and short-term prognosis in patients with acute ischemic stroke (AIS) undergoing intravenous thrombolysis with alteplase (rt-PA), and to develop a nomogram model for short-term prognosis prediction. The study collected data from cases of first-episode ischemic stroke treated with intravenous thrombolysis at Wuxi People’s Hospital. Patients were categorized into either a poor prognosis group (n = 78) or a good prognosis group (n = 119) based on the modified Rankin Rating Scale score 30 days post-treatment. The results showed that peripheral blood levels of NLR, PLR and SII were significantly elevated in the poor prognosis group compared to the good prognosis group (p < 0.05). Receiver operating characteristic (ROC) curve analysis revealed that the area under the curves (AUC) of NLR, PLR and SII for predicting poor prognosis of intravenous thrombolytic therapy in AIS patients were 0.674, 0.770 and 0.779, respectively. Multivariate regression analysis identified blood glucose concentration, pre-thrombolysis National Institutes of Health Stroke Scale (NIHSS) score, prothrombin time (PT), activated partial thromboplastin time (APTT), and SII as independent influencing factors for poor prognosis of intravenous thrombolytic therapy in AIS patients (p < 0.05). A nomogram model based on these seven independent influencing factors yielded an AUC of 0.929, with calibration curve and Hosmer-Lemeshow test (χ2 = 2.654, p = 0.954) confirming the model’s good fit. Decision analysis curves demonstrated the clinical benefit of utilizing predictive models in aiding clinical decision-making. In conclusion, peripheral blood systemic inflammatory marker SII was identified as a risk factor for poor short-term prognosis in patients treated with intravenous thrombolysis. The constructed nomogram incorporating inflammatory clinical features exhibited efficient and promising clinical utility in predicting early prognosis of AIS patients treated with rt-PA thrombolysis.

Alteplase; Intravenous thrombolysis; Acute ischemic stroke; Indicators of peripheral blood inflammation; Nomogram

[1] Herpich F, Rincon F. Management of acute ischemic stroke. Critical Care Medicine. 2020; 48: 1654–1663.

[2] Rabinstein AA. Update on treatment of acute ischemic stroke. Continuum: Lifelong Learning in Neurology. 2020; 26: 268–286.

[3] Qian B, Zheng Y, Jia H, Zheng X, Gao R, Li W. Neutrophil-lymphocyte ratio as a predictive marker for postoperative infectious complications: a systematic review and meta-analysis. Heliyon. 2023; 9: e15586.

[4] Farias JS, Villarreal EG, Savorgnan F, Acosta S, Flores S, Loomba RS. The use of neutrophil–lymphocyte ratio for the prediction of refractory disease and coronary artery lesions in patients with Kawasaki disease. Cardiology in the Young. 2023; 33: 1409–1417.

[5] Grotta JC. Intravenous thrombolysis for acute ischemic stroke. Continuum: Lifelong Learning in Neurology. 2023; 29: 425–442.

[6] Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke. JAMA. 2021; 325: 1088.

[7] Psychogios K, Tsivgoulis G. Intravenous thrombolysis for acute ischemic stroke: why not? Current Opinion in Neurology. 2022; 35: 10–17.

[8] Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021; 122: 474–488.

[9] Sarejloo S, Kheradjoo H, Es Haghi S, Hosseini S, Gargari MK, Azarhomayoun A, et al. Neutrophil-to-lymphocyte ratio and early neurological deterioration in stroke patients: a systematic review and meta-analysis. BioMed Research International. 2022; 2022: 8656864.

[10] Zhang R, Wu X, Hu W, Zhao L, Zhao S, Zhang J, et al. Neutrophil-to-lymphocyte ratio predicts hemorrhagic transformation in ischemic stroke: a meta-analysis. Brain and Behavior. 2019; 9: e01382.

[11] Huang G, Chen H, Wang Q, Hong X, Hu P, Xiao M, et al. High platelet-to-lymphocyte ratio are associated with post-stroke depression. Journal of Affective Disorders. 2019; 246: 105–111.

[12] Chu YW, Chen PY, Lin SK. Correlation between immune-inflammatory markers and clinical features in patients with acute ischemic stroke. Acta Neurologica Taiwanica. 2020; 29: 103–113.

[13] Pan J, Wang Z, Huang X, Xue J, Zhang S, Guo X, et al. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy. Advanced Materials. 2023; 35: e2301779.

[14] Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R, et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nature Communications. 2020; 11: 2488.

[15] Wang Y, Jiang G, Zhang J, Wang J, You W, Zhu J. Blood glucose level affects prognosis of patients who received intravenous thrombolysis after acute ischemic stroke? A meta-analysis. Frontiers in Endocrinology. 2023; 14: 1120779.

[16] Arteaga DF, Ulep R, Kumar KK, Southerland AM, Conaway MR, Faber J, et al. Collateral status, hyperglycemia, and functional outcome after acute ischemic stroke. BMC Neurology. 2022; 22: 408.

[17] Gong P, Liu Y, Gong Y, Chen G, Zhang X, Wang S, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. Journal of Neuroinflammation. 2021; 18: 51.

[18] Sharma D, Aravind S, Joseph S, Fagera N, Rajagopalan G. The role of monocyte to high-density lipoprotein cholesterol ratio in predicting the severity of acute ischemic stroke and its association with the NIHSS. The Journal of the Association of Physicians of India. 2023; 71: 11–12.

[19] Kazi SA, Siddiqui M, Majid S. Stroke outcome prediction using admission NIHSS in anterior and posterior circulation stroke. Journal of Ayub Medical College Abbottabad. 2021; 33: 274–278.

[20] Lippi G, Favaloro EJ, Franchini M. Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT. Journal of Thrombosis and Thrombolysis. 2012; 34: 360–366.

[21] Xiufu Z, Ruipeng L, Jun Z, Yonglong L, Yulin W, Jian Z, et al. Analysis of influencing factors of early neurological improvement after intravenous rt-PA thrombolysis in acute anterior circulation ischemic stroke. Frontiers in Neurology. 2022; 13: 1037663.

[22] Cheng Y, Wang Q, Niu G, Luo C. Correlation of atherosclerotic dyslipidemia with long-term stroke recurrence in patients undergoing intravenous thrombolysis for acute ischemic stroke. International Journal of General Medicine. 2023; 16: 1621–1629.

[23] Park SY. Nomogram: an analogue tool to deliver digital knowledge. The Journal of Thoracic and Cardiovascular Surgery. 2018; 155: 1793.

[24] Xie X, Yang J, Ren L, Hu S, Lian W, Xiao J, et al. Nomogram to predict symptomatic intracranial hemorrhage after intravenous thrombolysis in acute ischemic stroke in Asian population. Current Neurovascular Research. 2021; 18: 543–551.